Quick Answer
Ocean Biomedical, Inc. reported Stockholders Equity of -$97.62 million for fiscal year 2024.
Ocean Biomedical, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$97.62M | -1.4% |
| 2024 | -$96.26M | -6.1% |
| 2023 | -$90.76M | -738.9% |
| 2022 | -$10.82M | -62.4% |
| 2021 | -$6.66M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | -$92.40M | -21.9% | +5.3% |
| December 31, 2024 | -$97.62M | -7.6% | +0.5% |
| September 30, 2024 | -$98.08M | -30.4% | -5.8% |
| June 30, 2024 | -$92.74M | -50.4% | -22.4% |
| March 31, 2024 | -$75.78M | -38.4% | +16.5% |
| December 31, 2023 | -$90.76M | -738.9% | -20.7% |
| September 30, 2023 | -$75.22M | -664.8% | -22.0% |
| June 30, 2023 | -$61.66M | -546.5% | -12.6% |
- Ocean Biomedical, Inc. showed a decrease of -1.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2024 period, Ocean Biomedical, Inc.’s stockholders equity has declined by 1365.0% (from -$6.66 million to -$97.62 million).
- The most recent figure is from Ocean Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: